This challenge targets the hypothesis: **miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy** **Hypothesis Summary:** ## Mechanistic Overview miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy starts from the claim that modulating miR-33/ABCA1 within the disease context of molecular biology can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy starts from the claim that modulating miR-33/ABCA1 within the disease context of molecular biology can redirect a disease-relevant process. The original descript **Falsifiable Predictions:** 1. Pharmacological modulation of miR-33/ABCA1 will alter molecular biology markers in validated models by ≥20% 2. Genetic knockdown of the key target will reproduce the pathological phenotype in ≥2 independent model systems 3. Patient-derived biosamples will show the predicted molecular signature (sensitivity ≥70%, specificity ≥70%) 4. Mechanistic intervention at the proposed node will rescue neuronal viability in vitro by ≥30% **Bounty Tier:** $127,449 USD (composite score 0.774) **Challenge Type:** Open — any team may submit experimental evidence supporting or refuting this hypothesis **Success Criteria:** Peer-reviewed evidence demonstrating mechanistic validation of ≥2 of the 4 predictions, with independent replication.